Wednesday, 1 November 2023 Sun Pharma reported an increase of 11% in gross sales to Rs 12,031 crore with a 5% jump in net profit to Rs 2,375.5 crore for the second quarter ended September. India formulation sales were up by 11% to Rs 3842.5 crore, while those in the US increased by 4.2% to $ 430 million. Global specialty sales stood at $240 million, up 19.3% vs second quarter (Q2) last year, and accounted for 16.4% of Q2FY24 sales. The companyβs R&D investments stood at Rs 773 crore.
Economists Predict Strong, Holiday Sales Despite , Waning Black Friday Interest.
'Forbes' reports that over half of shoppers in the
United States are expected to skip this year's Black
Friday sales,..
Credit: Wibbitz Top Stories Duration: 01:30Published
Why Retailers, Have High Hopes , for the 2023 Holiday Season.
'Newsweek' reports that retail sales
are up from 2022 and businesses hope
to keep that momentum up. .
Businesses have a number of..
Credit: Wibbitz Top Stories Duration: 01:31Published
Sun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its... IndiaTimes
Wednesday, 1 November 2023
![Economists Predict Strong Holiday Sales Despite Waning Black Friday Interest [Video]](https://video.newsserve.net/300/v/20231122/1360989191-Economists-Predict-Strong-Holiday-Sales-Despite-Waning-Black.jpg)
![Why Retailers Have High Hopes for the 2023 Holiday Season [Video]](https://video.newsserve.net/300/v/20231121/1360933133-Why-Retailers-Have-High-Hopes-for-the-2023.jpg)
